NASDAQ:JAGX
Jaguar Health, Inc. Stock News
$0.318
+0.0248 (+8.46%)
At Close: May 03, 2024
Filament Health's Magdalena Biosciences JV with Jaguar Health completes import of coca leaf from Peru
07:00am, Wednesday, 20'th Sep 2023
Filament Health Corp (OTCQB:FLHLF) told investors that its Magdalena Biosciences joint venture (JV) with Jaguar Health has completed an import of coca leaf to Filament's Metro Vancouver research and d
Jaguar Health Shares Presentation Replay Link from September 11-13, 2023 H.C. Wainwright Annual Global Investment Conference
08:30am, Thursday, 14'th Sep 2023
Click here to access webcast replay Top line results expected late October 2023 for company's phase 3 OnTarget trial of crofelemer for preventative treatment of cancer therapy-related diarrhea Jaguar
Napo Pharmaceuticals, a Jaguar family company, reported completion August 17 of last patient last visit for its pivotal Phase 3 OnTarget trial of crofelemer for preventive treatment of cancer therapy-
Jaguar Health, Inc. (JAGX) Q2 2023 Earnings Call Transcript
10:42am, Monday, 14'th Aug 2023
Jaguar Health, Inc. (NASDAQ:JAGX ) Q2 2023 Earnings Conference Call August 14, 2023 8:30 AM ET Company Participants Lisa Conte - President and Chief Executive Officer Carol Lizak - Chief Financial Off
Jaguar Health to Hold Investor Webcast Monday, August 14th at 8:30 AM EDT Regarding Q2 2023 Financials & Corporate Updates
08:30am, Thursday, 10'th Aug 2023
Click here to register for webcast Company plans to file its Earnings Report on August 14, 2023 on Form 10-Q for the quarter ended June 30, 2023 SAN FRANCISCO, CA / ACCESSWIRE / August 10, 2023 / Jagu
Jaguar Health to Present Aug 4th at Wall Street Wonders Investment Group Luncheon in NYC
08:30am, Thursday, 03'rd Aug 2023
SAN FRANCISCO, CA / ACCESSWIRE / August 3, 2023 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company's founder, president and CEO, is presenting at an invitation-only lunch
Jaguar Health to Present June 21st at MedInvest Oncology Investor Conference
08:30am, Thursday, 15'th Jun 2023
Reminder: Ladenburg Thalmann to host virtual discussion June 22, 2023 at 1:00 PM EDT with Jaguar CEO and leading patient advocates on impact of cancer therapy-related diarrhea on patients & importance
Jaguar Animal Health, Inc. (JAGX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
11:02am, Tuesday, 13'th Jun 2023
After losing some value lately, a hammer chart pattern has been formed for Jaguar Animal Health, Inc. (JAGX), indicating that the stock has found support. This, combined with an upward trend in earnin
Jaguar Health to Present at Lytham Partners Spring 2023 Investor Conference & Participate in Animal Health Panel
08:30am, Tuesday, 16'th May 2023
Jaguar Animal Health's Canalevia®-CA1 is the first and only treatment for chemotherapy-induced diarrhea (CID) in dogs to receive FDA conditional approval and is widely available through prominent pet
Click here to register for webcast Company plans to file its Earnings Report on May 15, 2023 on Form 10-Q for the quarter ended March 31, 2023 SAN FRANCISCO, CA / ACCESSWIRE / May 12, 2023 / Jaguar He
How to Use Social Media to Make Money Trading Penny Stocks
06:00am, Friday, 12'th May 2023
Use these tips to utilize social media for trading penny stocks The post How to Use Social Media to Make Money Trading Penny Stocks appeared first on Penny Stocks to Buy, Picks, News and Information
Jaguar Health to Hold Investor Webcast Monday, May 15th at 8:30 AM EDT Regarding Q1 2023 Financials & Corporate Updates
08:30am, Monday, 08'th May 2023
Click here to register for webcast Company plans to file its Earnings Report on May 15, 2023 on Form 10-Q for the quarter ended March 31, 2023 SAN FRANCISCO, CA / ACCESSWIRE / May 8, 2023 / Jaguar Hea
Jaguar Health, Inc. (JAGX) Q4 2022 Earnings Call Transcript
02:13pm, Monday, 27'th Mar 2023
Jaguar Health, Inc. (NASDAQ:JAGX ) Q4 2022 Earnings Conference Call March 27, 2023 8:00 AM ET Company Participants Lisa Conte - President & Chief Executive Officer Carol Lizak - Chief Financial Office
Jaguar Health Announces Time Change for March 27th Investor Webcast to 8:00 AM EDT
01:30pm, Friday, 24'th Mar 2023
Click here to register for webcast Company plans to file its Annual Report on March 24, 2023 on Form 10-K for the fiscal year ended December 31, 2022 SAN FRANCISCO, CA / ACCESSWIRE / March 24, 2023 /
Jaguar Health to Hold Investor Webcast Monday, March 27th at 8:30 AM EDT Regarding Q4 2022 Financials & Corporate Updates
08:30am, Tuesday, 21'st Mar 2023
Click here to register for webcast Company plans to file its Annual Report on March 24, 2023 on Form 10-K for the fiscal year ended December 31, 2022 SAN FRANCISCO, CA / ACCESSWIRE / March 21, 2023 /